Dow Down 0.08% Nasdaq Down 0.35%

More On ASTM

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(ASTM)

-NasdaqCM
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.88
Beta:1.76
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:8.06 - 18.35
Volume:0
Avg Vol (3m):2,698
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-3.87
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for ASTM at this time.

Comparison

Symbol% ChgMkt Cap
ASTM 0.00%N/A
BAXUp 0.53%19.80B
JNJDown 0.03%282.14B
CYTXDown 0.07%27.28M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aastrom Biosciences, Inc., a clinical-stage biotechnology company, focuses on the development of cell therapies for use in the treatment of severe chronic ischemic cardiovascular diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback